HIGH-GRADE SEROUS OVARIAN CANCER
Clinical trials for HIGH-GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for HIGH-GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian cancer drug combo trial halted early
Disease control TerminatedThis phase 3 trial tested a combination of two targeted drugs, alpelisib and olaparib, against standard chemotherapy in 358 women with a tough-to-treat type of ovarian cancer that had stopped responding to platinum-based chemotherapy. The study only included women without a BRCA …
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New cancer drug trial halted early – what we know
Disease control TerminatedThis early-stage trial tested an experimental drug called NUV-868, alone or with other cancer drugs, in 82 adults with advanced solid tumors (including ovarian, pancreatic, prostate, and breast cancers). The goal was to find safe doses and check for early signs of effectiveness. …
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC